Health

  • February 17, 2026

    Chancery Disallows Arbitration In No Surprises Act Cases

    In a "narrow" first impression ruling, a Delaware magistrate in Chancery has rejected claims that the federal No Surprises Act provides for a narrow private right to seek the enforcement of an arbitration award in litigation over medical bills involving the act.

  • February 17, 2026

    Judge Rips Drugmakers' Borderline 'Disingenuous' Appeal Bid

    A Connecticut federal judge has rejected generic-drug makers' request for a quick appeal of his ruling denying them summary judgment on states' claims they engaged in an "overarching conspiracy" to fix prices, slamming the request for being borderline "disingenuous," mischaracterizing his reasoning and ignoring direct evidence of alleged wrongdoing.

  • February 17, 2026

    Union Says Express Scripts Diverted Billions In Kickback Fees

    A Chicago plumbers union healthcare fund told an Illinois federal court Tuesday that the nation's largest pharmacy benefit manager, Express Scripts, violated federal criminal law when it used a Switzerland-based company to hide kickbacks it generated by charging drug companies fees for key placement on prescription plan drug lists.  

  • February 17, 2026

    Conn. Judge Says Attys 'Unprepared' At Pretrial Conference

    A Connecticut state judge on Tuesday chastised the parties in a medical malpractice case where the plaintiffs have sought more than $12 million, saying they were "completely unprepared" and "utterly ignored" a previous scheduling order.

  • February 17, 2026

    Squires Ends IPR After ITC Judge Rejects Validity Challenge

    U.S. Patent and Trademark Office Director John Squires ended a Patent Trial and Appeal Board review of a Hydrafacial LLC skin treatment patent since the same issue had already been adjudicated in the U.S. International Trade Commission.

  • February 17, 2026

    McGuireWoods Adds Sidley Private Equity Pro In Los Angeles

    McGuireWoods LLP is expanding its transactional team, announcing Tuesday that it is bringing in a Sidley Austin LLP private equity expert as a partner in its Los Angeles office.

  • February 17, 2026

    Providence Health Inks $43M Deal In 401(k) Forfeiture Suit

    Providence Health & Services has struck a nearly $43 million deal to end a suit claiming the company used forfeited cash from its retirement plan to fund its employer contributions instead of plan expenses covered by workers, an agreement that stands to benefit 200,000 class members.

  • February 17, 2026

    3 Firms Advise On $9.9B Danaher, Masimo Diagnostics Deal

    Danaher Corp. said Tuesday it has agreed to acquire Masimo Corp. in a deal valued at about $9.9 billion, including debt, with Kirkland & Ellis LLP advising Danaher and Sullivan & Cromwell LLP and White & Case LLP representing Masimo. 

  • February 17, 2026

    Ex-Federal Workers Say Reductions Were 'Political' Firings

    A group of more than 140 ex-federal employees has sued the U.S. Department of Justice and other federal agencies in Maryland federal court, challenging the Trump administration's use of "reductions in force" to make what they contend are politically motivated firings.

  • February 17, 2026

    Colo. Judge Allows Hospital To Pause Gender-Affirming Care

    A Colorado state judge declined to reinstate gender-affirming care for transgender youth patients of Children's Hospital Colorado, ruling that ordering the hospital to resume providing the care could risk the hospital's ability to provide pediatric care to other patients.

  • February 17, 2026

    Nurse, Staffing Cos. Settle 'Indentured Servitude' Suit For $1M

    Two healthcare staffing companies will pay $1 million to end a proposed class and collective action claiming they engaged in "indentured servitude" by forcing nurses to repay visa-related costs, according to an Ohio federal court filing.

  • February 17, 2026

    Edwards Sued In Chancery Over $300M Heart Valve Earn-Out

    The former shareholders of Valtech Cardio Ltd. have sued the company and its parent Edwards Lifesciences Corp. in the Delaware Chancery Court, accusing the medical device giant of deliberately stalling development of a heart valve repair system to avoid paying up to $300 million in earn-out consideration tied to the 2016 acquisition.

  • February 17, 2026

    Home Health Co. Nurses Are Employees, Judge Rules

    A home healthcare company misclassified its licensed practical nurses as independent contractors, a Pennsylvania federal judge ruled in a suit brought by the U.S. Department of Labor, saying a jury should decide how much overtime the workers are owed.

  • February 13, 2026

    RFK Jr. Taps Ex-Jones Day Atty For FDA Senior Counselor

    U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. has named a former Jones Day partner as one of the U.S. Food and Drug Administration's senior counselors, according to an announcement.

  • February 13, 2026

    States' Generic Drugs Antitrust Case Headed Toward Trial

    A Connecticut federal judge has mostly refused to side with pharmaceutical companies facing states' generic drug price-fixing litigation against them, ruling that there are genuine disputes of material fact as to drug distribution chains and the states' antitrust standing and teeing up the case for trial.

  • February 13, 2026

    Health Exec Says He Was Fired For Opposing 'Enron-Style' Plot

    Jefferson Health System terminated its former vice president of facilities management over "his refusal to participate in" what he described as "an Enron-style financial engineering scheme" related to a proposed energy-as-a-service transaction that he believed posed serious regulatory risks, according to a suit filed in Pennsylvania.

  • February 13, 2026

    Ga. Judge Rejects 'Conspiracy Theories' Behind DQ Bid

    A Georgia federal judge rejected Friday a Florida couple's bid to disqualify the judge overseeing their medical malpractice case after it was tossed for using falsified video footage, writing that the effort was based on "nothing but speculative and attenuated conspiracy theories."

  • February 13, 2026

    Docs Urge Judge To Block CDC's Childhood Vaccine Changes

    Doctors organizations Friday urged a Massachusetts federal judge to stop the government from implementing its new, shorter list of recommended vaccines for children and prevent the next meeting of a committee they say has been tainted by anti-vaccine influence.

  • February 13, 2026

    Iowa AG Urges 8th Circ. To Unblock Parts Of State PBM Law

    The state of Iowa urged the Eighth Circuit on Friday to lift a preliminary block on parts of a law limiting pharmacy benefit managers' power to set drug prices in the Hawkeye State, arguing a lower court judge erred in holding that parts of the policy were federally preempted.

  • February 13, 2026

    State Lawmakers Advance Flurry Of Psilocybin Reform Bills

    Since the beginning of the year, lawmakers in several states have introduced and advanced numerous bills regarding psilocybin, the active compound in psychoactive mushrooms, including bills decriminalizing it, funding research into its medical uses and establishing a regulated medical program.

  • February 13, 2026

    Insurer Off The Hook For $2M Nursing Home Judgment

    A Georgia federal judge has rejected a family's attempts to force an insurer to pay for a $2 million personal injury judgment they secured against a nursing home, ruling the family unambiguously gave up their claims when accepting a settlement amid the nursing home's bankruptcy.

  • February 13, 2026

    Breast Surgery Patients Want ERISA Class Cert. Rethink

    A United Healthcare plan member asked a New Jersey federal judge to rethink her decision denying class certification in a suit alleging the insurer systematically refused to cover postmastectomy breast reconstruction claims, arguing the court overlooked evidence showing that common issues could be resolved on a classwide basis.

  • February 13, 2026

    FDA Removes Boxed Warnings From HRT Products

    Six menopause hormone therapies will no longer have warnings on their label about heart disease, breast cancer and dementia, after the U.S. Food and Drug Administration said it removed them so that women can make decisions "free from exaggeration or fear."

  • February 13, 2026

    Talc MDL Law Firm Accuses Litigation Funders Of Case Piracy

    A leading plaintiffs law firm in the multibillion-dollar litigation over Johnson & Johnson's tainted talcum powder has alleged in Mississippi federal court three investment firms loaned it "tens of millions" of dollars under false pretenses in a "loan-to-own" scheme.

  • February 13, 2026

    Olympus Slips Whistleblower Suit Over Testing Practices

    A Pennsylvania federal judge has dismissed a whistleblower lawsuit brought by the former head of product development for Olympus Corp. of the Americas, ruling that the ex-executive failed to show he was fired in retaliation for speaking out about what he alleged were company violations of the National Defense Authorization Act.

Expert Analysis

  • When Atty Ethics Violations Give Rise To Causes Of Action

    Author Photo

    Though the Model Rules of Professional Conduct make clear that a violation of the rules does not automatically create a cause of action, attorneys should beware of a few scenarios in which they could face lawsuits for ethical lapses, says Brian Faughnan at Faughnan Law.

  • What's New In FDA's Latest Cell And Gene Therapy Guidance

    Author Photo

    New draft guidance from the U.S. Food and Drug Administration, along with other recent initiatives, come together to promote cell and gene therapy product development by streamlining development and review pathways, say attorneys at Holland & Knight.

  • H-1B Fee Guidance Is Helpful But Notable Uncertainty Persists

    Author Photo

    Recent guidance narrowing the scope of the $100,000 entry fee for H-1B visas will allow employers to plan for the hiring season, but a lack of detail about the mechanics of cross-agency payment verification, fee exemptions and other practical matters still need to be addressed, say attorneys at Klasko Immigration Law Partners.

  • Risk Mitigation For Psychedelic Use In Reproductive Health

    Author Photo

    With the rising use of psychedelics among women of reproductive age and the absence of clear professional guidelines regarding risk labeling, healthcare providers and facilitators should adopt proactive, evidence-based approaches to mitigate malpractice liability risks, say Kimberly Chew at Husch Blackwell and Sara Shoar at the University of Southern California.

  • Justices' LabCorp Punt Leaves Deeper Class Cert. Circuit Split

    Author Photo

    In its ruling in LabCorp v. Davis, the U.S. Supreme Court left unresolved a standing-related class certification issue that has plagued class action jurisprudence for years — and subsequent conflicting decisions among federal circuit courts have left district courts and litigants struggling with conflicting and uncertain standards, say attorneys at Cozen O'Connor.

  • Series

    Practicing Stoicism Makes Me A Better Lawyer

    Author Photo

    Practicing Stoicism, by applying reason to ignore my emotions and govern my decisions, has enabled me to approach challenging situations in a structured way, ultimately providing advice singularly devoted to a client's interest, says John Baranello at Moses & Singer.

  • Adapting To Enforcement Focus On Wound Care Fraud

    Author Photo

    As federal agencies target wound care industry fraud as a top enforcement priority, attorneys advising industry stakeholders should evaluate business relationships for Anti-Kickback Statute violations, emphasize appropriate product use and documentation, and use internal data analytics to monitor billing patterns, say David Tarras at Tarras Defense and Jay McCormack at Verrill Dana.

  • Series

    The Biz Court Digest: Texas, One Year In

    Author Photo

    A year after the Texas Business Court's first decision, it's clear that Texas didn't just copy Delaware and instead built something uniquely its own, combining specialization with constitutional accountability and creating a model that looks forward without losing touch with the state's democratic and statutory roots, says Chris Bankler at Jackson Walker.

  • AI Product Safety Insights May Expand Foreseeability

    Author Photo

    Product liability law has long held that companies are responsible for risks they knew about or should have known about — and with AI systems now able to assess and predict hazards during the design process, companies should expect that courts will likely treat such hazards as foreseeable, says Donald Fountain at Clark Fountain.

  • AG Watch: Illinois A Key Player In State-Level Enforcement

    Author Photo

    Illinois Attorney General Kwame Raoul has systematically strengthened his office to fill federal enforcement gaps, oppose Trump administration mandates and advance state policy objectives, particularly by aggressively pursuing labor-related issues, say attorneys at Troutman.

  • Series

    Law School's Missed Lessons: Educating Your Community

    Author Photo

    Nearly two decades prosecuting scammers and elder fraud taught me that proactively educating the public about the risks they face and the rights they possess is essential to building trust within our communities, empowering otherwise vulnerable citizens and preventing wrongdoers from gaining a foothold, says Roger Handberg at GrayRobinson.

  • Organ Transplant System Reforms Mark Regulatory Overhaul

    Author Photo

    Recent oversight, enforcement and operational developments in the U.S. organ procurement and transplantation system, alongside challenges like the federal shutdown, highlight heightened regulatory scrutiny and the need for compliance to maintain public trust, say attorneys at Hall Render.

  • Federal Grantees May Soon Face More Limitations On Speech

    Author Photo

    If courts accept the administration’s new interpretation of preexisting case law, which attempts to graft onto grant recipients the existing limitations on government contractors' free speech, a more deferential standard may soon apply in determining whether an agency’s refusal or termination of a grant was in violation of the First Amendment, say attorneys at Venable.

  • 5 Crisis Lawyering Skills For An Age Of Uncertainty

    Author Photo

    As attorneys increasingly face unprecedented and pervasive situations — from prosecutions of law enforcement officials to executive orders targeting law firms — they must develop several essential competencies of effective crisis lawyering, says Ray Brescia at Albany Law School.

  • Anticipating FTC's Shift On Unfair Competition Enforcement

    Author Photo

    As the Federal Trade Commission signals that it will continue to challenge unfair or deceptive acts and practices under Section 5 of the FTC Act, but with higher evidentiary standards, attorneys counseling healthcare, technology, energy or pharmaceuticals clients should note several practice tips, says Thomas Stratmann at George Mason University.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.